An R package for assessing drug synergism/antagonism

Journal of Statistical Software

Volumn 34, Issue 6, 2010, Pages 1-18

  Boik, John C ^a   Narasimhan, Balasubramanian ^b  

^a New Earth BioMed   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Antagonism; Cytotoxicity; Loewe index; Mixlow method; R; Synergism

Indexed keywords

EID: 77953195359     PISSN: 15487660     EISSN: 15487660     Source Type: Journal    
DOI: 10.18637/jss.v034.i06     Document Type: Article

References (11)

1. Berenbaum MC (1989). "What is Synergy?" Pharmacological Reviews, 41(2), 93-141.
2. Boik JC, Newman RA (2008). "A Classification Model to Predict Synergism/Antagonism of Cytotoxic Mixtures Using Protein-Drug Docking Scores." BMC Pharmacology, 8, 13.
3. Boik JC, Newman RA, Boik RJ (2008). "Quantifying Synergism/Antagonism Using Nonlinear Mixed-Effects Modeling: A Simulation Study." Statistics in Medicine, 27(7), 1040-1061.
4. Chou TC, Talalay P (1984). "Quantitative Analysis of Dose-Effect Relationships: The Com-bined Effects of Multiple Drugs or Enzyme Inhibitors." Advances in Enzyme Regulation, 22,27-55.
5. Greco WR, Bravo G, Parsons JC (1995). "The Search for Synergy: A Critical Review from a Response Surface Perspective." Pharmacological Reviews, 47(2), 331-385.
6. Merlin JL (1994). "Concepts of Synergism and Antagonism." Anticancer Research, 14(6A), 2315-2319.
7. Pinheiro J, Bates D, DebRoy S, Sarkar D, R Development Core Team (2009). "nlme: Linear and Nonlinear Mixed Effects Models. R Package Version 3.1-92." URL http: //CRAN.R-project.org/package=nlme.
8. R Development Core Team (2009). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http: //www.R-project.org/.
9. Ritz C, Streibig JC (2005). "Bioassay Analysis Using R." Journal of Statistical Software, 12(5),1-22. URL http://www.jstatsoft.org/v12/i05/.
10. Tallarida RJ (2001). "Drug Synergism: Its Detection and Applications." The Journal of Pharmacology and Experimental Therapeutics, 298(3), 865-872.
11. Vonesh EF, Chinchilli VM, Pu K (1996). "Goodness-of-Fit in Generalized Nonlinear MixedEffects Models." Biometrics, 52(2), 572-587.